Table of Contents Table of Contents
Previous Page  17 / 20 Next Page
Information
Show Menu
Previous Page 17 / 20 Next Page
Page Background

JCN supplement

2015,Vol 29, No 5

17

PALLIATIVE WOUND CARE

recognise the signs of infection and

instigate and monitor treatment.

If a wound becomes infected,

exudate volume increases, becoming

viscous and potentially malodorous,

with management focusing on

treating the infection systemically

or topically. Antimicrobial dressings

may also be used. Although it

is recommended that they are

discontinued once infection has

resolved and the exudate volume

decreased (Wounds UK, 2013),

in palliative care a decision may

be made to continue the use

of antimicrobial dressings or

antibiotics, particularly where

they are contributing to symptom

management, such as lowering

temperature, making the skin cooler

and lessening exudate volume —

all of which may make a positive

contribution to the patient’s comfort.

Pain control

The International Association for the

Study of Pain (IASP, 1979) defined

pain, highlighting its ‘unpleasantness’

and that it is both a physical and

emotional experience. Importantly,

pain levels can be improved when

an early assessment is performed

and preventative measures taken

(WUWHS, 2007b).

Patients receiving palliative care

may have more than one pain, and

each may have a different cause. The

types of pain relevant to wounds in

palliative care are soft tissue, bone/

muscle, and neuropathic pain. For

soft tissue injury, the World Health

Organization (WHO) analgesic

ladder may be used

(www.who.int/

cancer/palliative/painladder/en/):

`

Step 1: non-opioid +/- adjuvant

`

Step 2: opioid for mild-to-

moderate pain, +/- non-opioid,

+/- adjuvant

`

Step 3: opioid for moderate-to-

severe pain, +/- non-opioid,

+/- adjuvant.

The EWMA (2002) position

statement established that the

majority of pain experienced by

patients with wounds was during

dressing changes. Thus, it is

important that clinicians choose

dressings which minimise pain at

dressing change and which can best

barrier protection, appropriate

dressings and silicone medical

adhesive removers can contribute

to optimal care. Not only is this a

professional responsibility (Nursing

and Midwifery Council [NMC], 2015),

but also a duty of care, and legal

responsibility in Civil and Criminal

law (Dunn and Leyshon, 2007).

REFERENCES

Adderley UJ, Holt IGS (2014) Topical agents

and dressings for fungating wounds.

Available online:

http://onlinelibrary

.

wiley.com/doi/10.1002/14651858.

Cochrane Database of Systematic Reviews

CD003948.pub3/full

Bird C (2000) Managing malignant

fungating wounds.

Prof Nurse

15(4): 253–6

British Dermatological Nursing Group

(2012)

Best Practice in Emollient Therapy

.

3rd edn. Available online:

www.bdng.org.

uk/documents/emollientbpg.pdf

Cameron J (2004) Exudate and care of the

peri-wound skin. Nurs Standard 19(7):

62–8

Collier M (2000) Management of patients

with fungating wounds — a holistic

approach.

Nurs Standard

46–52

Cutting K (2003) Wound exudate:

composition and functions.

Br J

Community Nurs

Supplement: 4–9

Draper C (2005) The management of

malodour and exudate in fungating

wounds.

Br J Nurs

54

Dunn D, Leyshon S (2007)

The legal, ethical

and professional aspects of wound care

.

Wound care Society No 1

European and US National Pressure Ulcer

Advisory panels (EPUAP and NPUAP),

Pan Pacific Pressure Injury Alliance

manage the volume of exudate being

produced, as this will help to reduce

the frequency of dressing changes.

AIM OF WOUND DRESSINGS

As said, the overall aim of palliative

wound care is to manage exudate,

odour, pain, and bleeding (Adderley

and Holt, 2014), thereby keeping the

patient as comfortable as possible.

Several modern wound management

categories, including alginates,

silicones and foams can help to

achieve this aim.

Clinicians should consider several

questions to guide their dressing

choice (Stephen-Haynes, 2014),

namely:

`

Is the dressing conformable

and comfortable?

`

Is it suitable to be left in place for

a long duration?

`

Will the dressing prevent leakage

between dressing changes?

`

Does the periwound area need a

preventative skin protector?

`

Is it easy to remove?

`

Is it easy to use?

`

Is it cost-effective?

`

What sizes are available?

When removing dressings, it is

important to prevent pain, trauma,

and bleeding, or cause any damage

to the periwound skin. Where an

adhesive dressing is used, a silicone

adhesive remover may help with

pain-free dressing removal (Stephen-

Haynes, 2008).

CONCLUSION

Palliative wound care requires

clinicians to consider several factors

in relation to assessment, prevention,

management and maintenance.

By introducing effective wound

management plans that reduce

symptoms such as malodour, exudate

leakage, pain and bleeding, clinicians

can not only improve the patient’s

quality of life but also lessen the

burden for family members who are

caring for a relative who is dying. It is

also important to provide information

and offer practical and emotional

support. Appropriate preventative

strategies are also essential due to

skin changes and decreased general

health. The use of emollients,

i

Practice point

Malignant wounds situated near

major blood vessels can be at risk

of severe bleeding (haemorrhage).

Such bleeding can be extremely

frightening both to patients and

their families and, indeed, less

experienced staff. Dark towels or

blankets can mask the appearance

of blood and having experienced

healthcare professionals on hand

can help to provide support in

these situations.

JCN